Literature DB >> 6697863

Local inhibition of myoelectrical activity of human colon by loperamide.

I Altaparmakov, M Wienbeck.   

Abstract

In order to study whether the antidiarrheal effects of loperamide are largely brought about by a local inhibition of the drug, we applied doses of 0.2 mg directly on the mucosa of the descending and sigmoid colon of 33 healthy volunteers. Loperamide decreased BER frequencies and reduced spike activity to 6.6 +/- 0.3% of time vs 11.3 +/- 0.7% in the control recorded from 3 cm aside and to 5.8 +/- 0.4% vs 12.7 +/- 0.9% in the descending and sigmoid colon, respectively. The same effects became apparent when spike activity was stimulated by neostigmine. Loperamide also reduced the occurrence of groups of spikes to 3.8 +/- 0.4/hr vs 10.3 +/- 0.6 and to 3.6 +/- 0.4/hr vs 14.6 +/- 0.7 in the descending and sigmoid colon, respectively. Groups of spikes are thought to be the equivalent of propulsive movements. Thus, loperamide is active locally and exhibits inhibitory effects on the motor activity of the colon. Clinical studies seem warranted to examine the effectiveness of loperamide enemas in motility disturbances of the anorectum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697863     DOI: 10.1007/bf01296257

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Opiate agonist action of antidiarrheal agents in vitro and in vivo--findings in support for selective action.

Authors:  M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

2.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues.

Authors:  J M Van Nueten; P A Janssen; J Fontaine
Journal:  Arzneimittelforschung       Date:  1974-10

3.  Loperamide in the symptomatic control of chronic diarrhoea. Double-blind placebo-controlled study.

Authors:  G N Tijtgat; S G Meuwissen; K Huibregtse
Journal:  Ann Clin Res       Date:  1975-10

4.  Types of human colonic electrical activities recorded postoperatively.

Authors:  S K Sarna; W E Waterfall; B L Bardakjian; J F Lind
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

5.  Comparison between narcotic "receptors" in the guinea-pig ileum and the rat brain.

Authors:  L Terenius
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-09

6.  Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency.

Authors:  M Read; N W Read; D C Barber; H L Duthie
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

7.  The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat.

Authors:  J Hardcastle; P T Hardcastle; N W Read; J S Redfern
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

8.  Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin.

Authors:  U M Farack; U Kautz; K Loeschke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

9.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man.

Authors:  J Heykants; M Michiels; A Knaeps; J Brugmans
Journal:  Arzneimittelforschung       Date:  1974-10

10.  The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation.

Authors:  A M CONNELL
Journal:  Gut       Date:  1962-12       Impact factor: 23.059

View more
  3 in total

1.  Stimulation of gastrointestinal motility by loperamide in dogs.

Authors:  J Fioramonti; M J Fargeas; L Bueno
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

Review 2.  Control of human colonic motor function.

Authors:  J D Huizinga; E E Daniel
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

Review 3.  Loperamide. Survey of studies on mechanism of its antidiarrheal activity.

Authors:  F Awouters; A Megens; M Verlinden; J Schuurkes; C Niemegeers; P A Janssen
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.